|
RPN1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.917400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.171940E-02 |
| Normal-vs-Stage2 |
9.260000E-01 |
| Normal-vs-Stage3 |
4.05970000000311E-05 |
| Normal-vs-Stage4 |
1.998800E-04 |
| Stage1-vs-Stage2 |
1.644040E-02 |
| Stage1-vs-Stage3 |
1.287950E-02 |
| Stage1-vs-Stage4 |
2.964100E-02 |
| Stage2-vs-Stage3 |
2.767400E-04 |
| Stage2-vs-Stage4 |
1.536400E-03 |
| Stage3-vs-Stage4 |
7.727800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.629400E-04 |
| Normal-vs-AfricanAmerican |
2.245600E-01 |
| Normal-vs-Asian |
6.964100E-04 |
| Caucasian-vs-AfricanAmerican |
3.674000E-01 |
| Caucasian-vs-Asian |
8.267600E-01 |
| AfricanAmerican-vs-Asian |
4.126200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.285500E-02 |
| Normal-vs-Female |
2.819300E-03 |
| Male-vs-Female |
5.362200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.386050E-02 |
| Normal-vs-Age(41-60Yrs) |
3.424500E-03 |
| Normal-vs-Age(61-80Yrs) |
2.005000E-03 |
| Normal-vs-Age(81-100Yrs) |
9.838800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.054200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.342600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.231200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.153000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.262600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.000000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.37689970536314E-10 |
| Classical-VS-Follicular |
1.383150E-04 |
| Classical-VS-Other |
3.378400E-01 |
| Classical-VS-Normal |
4.396900E-04 |
| Tall-VS-Follicular |
1.8508528043526E-12 |
| Tall-VS-Other |
2.256600E-01 |
| Tall-VS-Normal |
2.02904359980494E-12 |
| Follicular-VS-Other |
5.986200E-02 |
| Follicular-VS-Normal |
6.096200E-01 |
| Other-VS-Normal |
1.449890E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.093220E-01 |
| Normal-vs-N1 |
2.01590000248331E-08 |
| N0-vs-N1 |
1.96360000037643E-07 |
|
|
